[
    {
        "file_name": "CnsPharmaceuticalsInc_20200326_8-K_EX-10.1_12079626_EX-10.1_DevelopmentAgreement.txt",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "within thirty Business Days from the date of this Agreement, CNS will make an upfront payment of $225,000 to WPD; and (ii) within thirty days of the verified achievement of the Phase II Milestone, (such verification shall be conducted by an independent third party mutually acceptable to the parties hereto), CNS will make a payment of $775,000 to WPD.",
                "changed_text": "within sixty Business Days from the date of this Agreement, CNS will make an upfront payment of $225,000 to WPD; and (ii) within ninety days of the verified achievement of the Phase II Milestone, (such verification shall be conducted by an independent third party mutually acceptable to the parties hereto), CNS will make a payment of $775,000 to WPD.",
                "explanation": "Delaying the payment deadlines may create issues with prompt payment laws, which in some jurisdictions require payments to be made within a specific timeframe (often shorter than 60 or 90 days) to avoid penalties.",
                "contradicted_law": "Potential violation of state prompt payment laws.",
                "location": "2.1"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "The first Development Fees payment shall be due forty-five days after the end of the Calendar Quarter in which the first Sale of a Development Product took place. Thereafter, WPD shall furnish to CNS Development Fees no later than forty-five days after the end of each Calendar Quarter for the Sale of Development Products through the end of such Calendar Quarter and shall further furnish CNS with a written statement setting forth an accounting showing the calculation of the Development Fees.",
                "changed_text": "The first Development Fees payment shall be due ninety days after the end of the Calendar Quarter in which the first Sale of a Development Product took place. Thereafter, WPD shall furnish to CNS Development Fees no later than ninety days after the end of each Calendar Quarter for the Sale of Development Products through the end of such Calendar Quarter and shall further furnish CNS with a written statement setting forth an accounting showing the calculation of the Development Fees.",
                "explanation": "Extending the payment deadline for Development Fees to 90 days after the end of the calendar quarter may conflict with standard commercial practices and potentially violate implied duties of good faith and fair dealing, especially if it causes undue hardship to CNS. Additionally, it might contradict accounting standards that require timely revenue recognition.",
                "contradicted_law": "Potential breach of implied duties of good faith and fair dealing under contract law and possible conflict with revenue recognition standards.",
                "location": "2.3"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "During the term of this Agreement and for a period of five (5) years thereafter, the Parties each agree that Confidential Information of the disclosing party, which is disclosed to the recipient party pursuant to this Agreement: (i) shall be received and held in strict confidence, (ii) shall be used only for the purposes of this Agreement, and (iii) will not be disclosed by the recipient party (except as required by law, court order or regulation), its agents or employees without the prior written consent of the disclosing party, except to the extent that the recipient party can establish by competent written proof that particular Confidential Information",
                "changed_text": "During the term of this Agreement and for a period of one (1) year thereafter, the Parties each agree that Confidential Information of the disclosing party, which is disclosed to the recipient party pursuant to this Agreement: (i) shall be received and held in strict confidence, (ii) shall be used only for the purposes of this Agreement, and (iii) will not be disclosed by the recipient party (except as required by law, court order or regulation), its agents or employees without the prior written consent of the disclosing party, except to the extent that the recipient party can establish by competent written proof that particular Confidential Information",
                "explanation": "Reducing the confidentiality period from 5 years to 1 year could be deemed insufficient to protect trade secrets, violating state trade secret laws (e.g., Uniform Trade Secrets Act) if the confidential information constitutes a trade secret and its value persists beyond one year.",
                "contradicted_law": "Potential violation of state trade secret laws (e.g., Uniform Trade Secrets Act).",
                "location": "5.1"
            }
        ]
    }
]